Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors
The DOI matches its Crossref record.
Abstract
Hepatotoxicity is an adverse effect of all available classes of antiretrovirals, including nucleoside reverse transcriptase inhibitors (NRTI). A syndrome of hepatic steatosis and lactic acidosis has been recognized as a rare, potentially fatal complication since the advent of NRTI monotherapy in the early 1990s. Today, NRTI remain the backbone of antiretroviral combination regimens, and, with the success of current treatment strategies, exposure to two or more of these agents may occur over a number of years. Hepatic steatosis and lactic acidosis are accordingly being observed more frequently, along with a more recently recognized syndrome of chronic hyperlactatemia. These as well as other adverse effects of NRTI are mediated by inhibition of human DNA polymerase gamma, resulting in mitochondrial dysfunction in the liver and other tissues. Early recognition and intervention are essential to avert serious outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although mouse studies suggest that NRTIs are an effective treatment option for L1-driven age-associated inflammation and pathologies, chronic NRTI treatment has been shown to induce adverse side effects in human patients, such as hepatotoxicity, as it also inhibits the mitochondrial DNA polymerase γ (Montessori et al., 2003; Wu et al., 2017).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Montessori et al., 2003
Citations
Cites
Still being checked.
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
David, S., & Hamilton, J. P. (2010) · PubMed · Cited by 407
Han, D., Dara, L., Win, S., Than, T. A., Yuan, L., Abbasi, S. Q., Liu, Z.-X., & Kaplowitz, N. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.009 · Cited by 196
Clinical Syndromes and Consequences of Antiretroviral-Related Hepatotoxicity5, 1, 3
Núñez, M. (2010) · Hepatology · doi:10.1002/hep.23716 · Cited by 178
Terefe, E. M., & Ghosh, A. (2022) · Bioinformatics and Biology Insights · doi:10.1177/11779322221125605 · Cited by 177
HIV and hepatitis C virus co-infection
Rockstroh, J. K., & Spengler, U. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01059-x · Cited by 173
Sarrazin, C., Berg, T., Ross, R., Schirmacher, P., Wedemeyer, H., Neumann, U., Schmidt, H., Spengler, U., Wirth, S., Kessler, H., et al. (2010) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0028-1110008 · Cited by 168
Cho, T., & Uetrecht, J. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00357 · Cited by 150
Yimer, G., Amogne, W., Habtewold, A., Makonnen, E., Ueda, N., Suda, A., Worku, A., Haefeli, W. E., Burhenne, J., Aderaye, G., et al. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.34 · Cited by 125
Gardner, K., Hall, P. A., Chinnery, P. F., & Payne, B. A. I. (2014) · Toxicologic Pathology · doi:10.1177/0192623313503519 · Cited by 103
Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
Uetrecht, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00837 · Cited by 91
WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs
Walsh, N. M., Verster, A. D., Rodolph, M., & Akl, E. A. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.01.009 · Cited by 91
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients
Novick, D. M., & Kreek, M. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02188.x · Cited by 86
Hulgan, T., Shepherd, B. E., Raffanti, S. P., Fusco, J. S., Beckerman, R., Barkanic, G., & Sterling, T. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/510536 · Cited by 75
Epidemiology of HIV and Response to Antiretroviral Therapy in the Middle Aged and Elderly
Gebo, K. A. (2008) · Aging Health · doi:10.2217/1745509x.4.6.615 · Cited by 60
HIV and Aging: Implications for Patient Management
Gebo, K. A. (2006) · Drugs & Aging · doi:10.2165/00002512-200623110-00005 · Cited by 68
HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications.
Andreoni, M., Giacometti, A., Maida, I. R., Meraviglia, P., Ripamonti, D., & Sarmati, L. (2012) · PubMed · Cited by 67
Hulgan, T., Raffanti, S. P., Kheshti, A., Blackwell, R. B., Rebeiro, P. F., Barkanic, G., Ritz, B., & Sterling, T. R. (2005) · The Journal of Infectious Diseases · doi:10.1086/432955 · Cited by 55
The Relationship between Nevirapine Plasma Concentrations and Abnormal Liver Function Tests
Almond, L. M., Boffito, M., Hoggard, P. G., Bonora, S., Raiteri, R., Reynolds, H. E., Garazzino, S., Sinicco, A., Khoo, S., Back, D. J., et al. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/0889222041524670 · Cited by 51
Management of Gastrointestinal Disorders in Children with HIV Infection
Guarino, A., Bruzzese, E., Marco, G. D., & Buccigrossi, V. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406060-00003 · Cited by 49
Drug-induced liver disease in 2003
Pishvaian, A. C., Trope, B. W., & Lewis, J. H. (2004) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200405000-00005 · Cited by 41
Nucleoside Reverse Transcriptase Inhibitors, Mitochondrial Dna and Aids Therapy
Lewis, W. (2005) · Antiviral Therapy · doi:10.1177/135965350501002s03 · Cited by 40
Pasqua, L. G. D., Cagna, M., Berardo, C., Vairetti, M., & Ferrigno, A. (2022) · Biomedicines · doi:10.3390/biomedicines10010194 · Cited by 37
HIV and liver disease forum: Conference proceedings
Sherman, K. E., Peters, M. G., & Koziel, M. J. (2007) · Hepatology · doi:10.1002/hep.21722 · Cited by 32
Sarrazin, C., Roß, R. S., Schirmacher, P., Wedemeyer, H. H., Neumann, U. P., Schmidt, H., Spengler, U., Wirth, S., Kessler, H. H., Peck‐Radosavljevic, M., et al. (2010) · Cited by 32
Hyperbilirubinemia in the setting of antiviral therapy
Korenblat, K., & Berk, P. D. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00083-2 · Cited by 25
Feld, J. J., Ocama, P., & Ronald, A. (2005) · Antiviral Therapy · doi:10.1177/135965350501000803 · Cited by 23
Bonkovsky, H. L., Jones, D. P., Russo, M. W., & Shedlofsky, S. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00025-5 · Cited by 24
HIV-1, HCV and Alcohol in the CNS: Potential Interactions and Effects on Neuroinflammation
Silverstein, P. S., Kumar, S., & Kumar, A. (2014) · Current HIV Research · doi:10.2174/1570162x12666140721122956 · Cited by 20
Drug-induced liver steatosis in patients with HIV infection
Gervasoni, C., Cattaneo, D., Fìlice, C., & Galli, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104267 · Cited by 17
Peters, M. G., & Soriano, V. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch22 · Cited by 13
Kahraman, A., Miller, M., Gieseler, R. K. H., Gerken, G., Scolaro, M. J., & Canbay, A. E. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00018 · Cited by 13
Bonkovsky, H. L., Jones, D. P., LaBrecque, D. R., & Shedlofsky, S. I. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50031-0 · Cited by 15
Recognition of Hepatitis C Virus Coinfection in HIV-Positive Injecting Drug Users in Asia
Walsh, N. M., Higgs, P., & Crofts, N. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318050d8d8 · Cited by 10
Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury
Roth, R. A., Kana, O. Z., Filipovic, D., & Ganey, P. E. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2113379 · Cited by 9
Protective Effects of Calpurnia aurea Seed Extract on HAART Hepatotoxicity
Mulata, H., Seifu, D., Umeta, M., Ergete, W., & Gnanasekaran, N. (2015) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2015/17677 · Cited by 8
Antiretroviral-associated hepatotoxicity
Kress, K. D. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0068-z · Cited by 7
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_14 · Cited by 6
Lipke, K., Kubis-Kubiak, A., & Piwowar, A. (2023) · Pharmaceuticals · doi:10.3390/ph16121661 · Cited by 6
Devarbhavi, H. C., Bonkovsky, H. L., Russo, M. W., & Chalasani, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00056-2 · Cited by 11
Scherpbier, H. J., Terpstra, V., Pajkrt, D., Puthakanit, T., Ananworanich, J., Foster, C., Weerman, M. A. V. D. B., Deurloo, E. E., van der Valk, M., Kuijpers, T. W., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001202 · Cited by 5
Li, Y., & Zhou, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00008-6 · Cited by 5
Miller, M., Kahraman, A., Ross, B., Beste, M., & Gerken, G. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-9-369 · Cited by 5
Should autism be considered a canary bird telling thatHomo sapiensmay be on its way to extinction?
Christophersen, O. A. (2012) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v23i0.19008 · Cited by 5
Mitochondrial Toxicity of Antiviral Drugs: A Challenge to Accurate Diagnosis
de Baar, M. P., & de Ronde, A. (2008) · Wiley eBooks · doi:10.1002/9780470372531.ch20 · Cited by 4
Clinical management of HIV/hepatitis C virus coinfection
Pozza, R. (2008) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2008.00351.x · Cited by 4
Hu, J., Mao, T., Huang, K., Yang, S., Yu, W., Huang, J., Jin, S., Sun, C., Jiapaer, Z., & Wang, X. (2026) · Cell Cycle · doi:10.1080/15384101.2025.2611968 · Cited by 3
Hepatotoxicity of Antiviral Agents
Núñez, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00028-5 · Cited by 3
Inhibition of retrotransposition improves health and extends lifespan of SIRT6 knockout micePreprint
Simon, M., Meter, M. V., Ablaeva, J., Ke, Z., González, R. S., Taguchi, T., Cecco, M. D., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/460808 · Cited by 3
Sherman, K. E., & Sterling, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00037-9 · Cited by 4
Challenges in the treatment of HIV and HCV coinfection
Streeck, H., & Rockstroh, J. K. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.5.811 · Cited by 2
Liver-Related Complications in HIV-Infected Individuals
Chun, H., & Landrum, M. L. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000246152.78893.40 · Cited by 3
HIV Co-Infection Drug Toxicity
McGovern, B., Sulkowski, M., & Sterling, R. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00038-3 · Cited by 1
Wenderlein, D., & Scarcella, P. (2016) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000537 · Cited by 1
Therapy of hepatitis C in patients with HIV infection
Daugherty, T. J., & Bonacini, M. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.3.375 · Cited by 1
(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_29 · Cited by 1
Bannister, W. P. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Biochemical mechanisms of drug toxicity
Uetrecht, J., Grant, D. M., & Wells, P. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819869-8.00015-x · Cited by 3
Current awareness: Pharmacoepidemiology and drug safety
(2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.933
(2009) · Springer eBooks · doi:10.1007/978-3-540-76839-5_29
Metadata
- Authors
- Montessori, V., Harris, M., & Montaner, J. S. G.
- Affiliations
- University of British Columbia (CA)
- BC Centre for Excellence in HIV/AIDS (CA)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003
- Volume
- 23
- Issue
- 2
- Pages
- 167-172
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2464563939
- Cited by
- 62
- References
- 0
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2019: 4 · 2018: 3 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 4
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- nucleoside reverse transcriptase inhibitors, hepatotoxicity, lactic acidosis, hepatic steatosis, mitochondrial dysfunction, antiretroviral therapy, HIV infection, adverse drug reactions
- MeSH terms
- Humans, Liver, Mitochondria, Liver, HIV Infections, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.